Rock Springs Capital Management LP Ironwood Pharmaceuticals Inc Transaction History

Rock Springs Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $2.5 Million - $3.07 Million	-225,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $304,000 - $364,500	25,000 Added 12.5%	225,000 $3.37 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $2.41 Million - $2.97 Million	200,000	200,000 $3.15 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.